At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 82 enrolled
Drug / intervention
Detemir +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transitioning Post-cardiothoracic Surgery Patients From Intravenous Insulin to the Subcutaneous Route With Insulin Detemir.
In Brief
A Phase 4 clinical trial evaluating Detemir for Diabetes Mellitus. Completed, enrolled 82 participants across 1 site.
Detailed Summary
In this study we will determine the proper method for transitioning patients from a continuous insulin infusion to periodic injections of a newer long-acting insulin called detemir (Levemir).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited States
CollaboratorsNovo Nordisk A/S
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
First PostedJul 2008
Primary CompletionMar 2010
Study CompletionJun 2010
TodayJul 2026
First PostedJul 17, 2008
Enrollment StartJul 1, 2008
Primary CompletionMar 1, 2010
Study CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 18.0 years ago
Interventions
Detemirdrug
Detemir dosed at 50% of calculated basal insulin infusion requirements
Detemirdrug
Detemir dosed at 65% of calculated basal insulin infusion requirements
Detemirdrug
Detemir dosed at 80% of calculated basal insulin infusion requirements